Ramos CA - Search Results

1

Side-effect management of chimeric antigen receptor (CAR) T-cell therapy.

Schubert ML, Schmitt M, Wang L, Ramos CA, Jordan K, Müller-Tidow C, Dreger P. Schubert ML, et al. Among authors: ramos ca. Ann Oncol. 2021 Jan;32(1):34-48. doi: 10.1016/j.annonc.2020.10.478. Epub 2020 Oct 21. Ann Oncol. 2021. PMID: 33098993 Free article. Review.

2

Chimeric antigen receptor (CAR)-engineered lymphocytes for cancer therapy.

Ramos CA, Dotti G. Ramos CA, et al. Expert Opin Biol Ther. 2011 Jul;11(7):855-73. doi: 10.1517/14712598.2011.573476. Epub 2011 Apr 4. Expert Opin Biol Ther. 2011. PMID: 21463133 Free PMC article. Review.

3

CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients.

Savoldo B, Ramos CA, Liu E, Mims MP, Keating MJ, Carrum G, Kamble RT, Bollard CM, Gee AP, Mei Z, Liu H, Grilley B, Rooney CM, Heslop HE, Brenner MK, Dotti G. Savoldo B, et al. Among authors: ramos ca. J Clin Invest. 2011 May;121(5):1822-6. doi: 10.1172/JCI46110. Epub 2011 Apr 11. J Clin Invest. 2011. PMID: 21540550 Free PMC article.

4

CD19-CAR trials.

Ramos CA, Savoldo B, Dotti G. Ramos CA, et al. Cancer J. 2014 Mar-Apr;20(2):112-8. doi: 10.1097/PPO.0000000000000031. Cancer J. 2014. PMID: 24667955 Free PMC article. Review.

5

Xu Y, Zhang M, Ramos CA, Durett A, Liu E, Dakhova O, Liu H, Creighton CJ, Gee AP, Heslop HE, Rooney CM, Savoldo B, Dotti G. Xu Y, et al. Among authors: ramos ca. Blood. 2014 Jun 12;123(24):3750-9. doi: 10.1182/blood-2014-01-552174. Epub 2014 Apr 29. Blood. 2014. PMID: 24782509 Free PMC article. Clinical Trial.

6

CAR-T Cell Therapy for Lymphoma.

Ramos CA, Heslop HE, Brenner MK. Ramos CA, et al. Annu Rev Med. 2016;67:165-83. doi: 10.1146/annurev-med-051914-021702. Epub 2015 Aug 26. Annu Rev Med. 2016. PMID: 26332003 Free PMC article. Review.

7

Expanding Accessibility to CD19-CAR T Cells: Commercializing a "Boutique" Therapy.

Lulla P, Ramos CA. Lulla P, et al. Among authors: ramos ca. Mol Ther. 2017 Jan 4;25(1):8-9. doi: 10.1016/j.ymthe.2016.12.002. Epub 2017 Jan 4. Mol Ther. 2017. PMID: 28129132 Free PMC article. No abstract available.

8

Clinical and immunological responses after CD30-specific chimeric antigen receptor-redirected lymphocytes.

Ramos CA, Ballard B, Zhang H, Dakhova O, Gee AP, Mei Z, Bilgi M, Wu MF, Liu H, Grilley B, Bollard CM, Chang BH, Rooney CM, Brenner MK, Heslop HE, Dotti G, Savoldo B. Ramos CA, et al. J Clin Invest. 2017 Sep 1;127(9):3462-3471. doi: 10.1172/JCI94306. Epub 2017 Aug 14. J Clin Invest. 2017. PMID: 28805662 Free PMC article. Clinical Trial.

9

Cancer Immunotherapy Using CAR-T Cells: From the Research Bench to the Assembly Line.

Gomes-Silva D, Ramos CA. Gomes-Silva D, et al. Among authors: ramos ca. Biotechnol J. 2018 Feb;13(2):10.1002/biot.201700097. doi: 10.1002/biot.201700097. Epub 2017 Oct 30. Biotechnol J. 2018. PMID: 28960810 Free PMC article. Review.

10

The use of chimeric antigen receptor T cells in patients with non-Hodgkin lymphoma.

Lulla PD, Hill LC, Ramos CA, Heslop HE. Lulla PD, et al. Among authors: ramos ca. Clin Adv Hematol Oncol. 2018 May;16(5):375-386. Clin Adv Hematol Oncol. 2018. PMID: 29851933 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

166 results

Search Page

Filters